Skip to main content
FinSpry Logo
FinSpry
LYEL logo
LYEL
(NASDAQ)
Lyell Immunopharma, Inc.
$17.22-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lyell Immunopharma (LYEL) Stock Price & Financial Analysis

Lyell Immunopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.23 - $17.30
52-Week High$45.00
52-Week Low$7.65
Open$16.26
Volume82.09K
Average Volume (3M)78.47K
Market Cap275.71M
Shares Outstanding17.09M
Price to Sales (P/S)7658.61
Price to Book (P/B)1.11
EV/EBITDA-1.35
Revenue (TTM)36.00K
Net Income (TTM)-274.45M
Free Cash Flow (TTM)-150.80M
EPS (TTM)$-15.89
Profit Margin-762355.56%
Operating Margin-560080.56%
Return on Equity (ROE)-110.57%
Debt to Equity0.17
50-Day MA$21.86
200-Day MA$20.26
52-Week Change127.70%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lyell Immunopharma

What is the current stock price for LYEL?

As of the latest trading session, LYEL stock trades at $17.22. The 52-week range is $7.65–$45.00, with a day range of $16.23–$17.30.

What is the P/E ratio for LYEL?

The P/E ratio (Price-to-Earnings) for LYEL is shown in the Key Statistics section. This valuation metric helps compare Lyell Immunopharma, Inc. to industry peers.

Does LYEL pay dividends?

Lyell Immunopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LYEL?

Based on 2 analysts, the consensus for LYEL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LYEL?

Lyell Immunopharma's market capitalization is $294.3M, classifying it as a micro-cap company. Lyell Immunopharma operates in the Healthcare sector within the Biotechnology industry.